SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SanBio Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| January 31, 2020 | 0.366 |
| October 31, 2019 | 0.3151 |
| July 31, 2019 | 0.2884 |
| April 30, 2019 | 0.5003 |
| January 31, 2019 | 0.4527 |
| October 31, 2018 | 0.2699 |
| July 31, 2018 | 0.256 |
| April 30, 2018 | 0.7982 |
| January 31, 2018 | 2.696 |
| October 31, 2017 | 1.606 |
| July 31, 2017 | 0.968 |
| Date | Value |
|---|---|
| April 30, 2017 | 0.661 |
| January 31, 2017 | 0.2829 |
| October 31, 2016 | 0.3117 |
| July 31, 2016 | 0.1499 |
| April 30, 2016 | 0.1636 |
| January 31, 2016 | 0.1885 |
| October 31, 2015 | 0.1745 |
| July 31, 2015 | 0.1738 |
| April 30, 2015 | 0.1664 |
| January 31, 2015 | -13.75 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2884
Minimum
Jul 2019
0.366
Maximum
Jan 2020
0.3232
Average
0.3151
Median
Oct 2019
Debt to Equity Ratio Benchmarks
| Takeda Pharmaceutical Co Ltd | 0.666 |
| Nxera Pharma Co Ltd | 1.027 |
| PeptiDream Inc | 0.5396 |
| Healios KK | 1.196 |
| AnGes Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.25M |
| Total Liabilities (Quarterly) | 15.30M |
| Shareholders Equity (Quarterly) | 18.95M |